Dara Azar

Stock Analyst at Stifel Nicolaus

(2.30)

# 2,956

Out of 4,357 analysts

9

Total ratings

50%

Success rate

13.2%

Average return

Main Sectors:

Top Industries:

Stocks Rated by Dara Azar

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	SMMT Summit Therapeutics	Maintained: Buy	$45	$15.71	+186.44%	5	Jun 1, 2026
	INBX Inhibrx Biosciences	Reiterated: Buy	$300 → $325	$99.29	+227.32%	4	May 15, 2026

Summit Therapeutics

Jun 1, 2026

Maintained: Buy

Price Target: $45

Current: $15.71

Upside: +186.44%

Inhibrx Biosciences

May 15, 2026

Reiterated: Buy

Price Target: $300 → $325

Current: $99.29

Upside: +227.32%